London, 01 October 2014: TechNavio, the independent tech-focused global research firm, has published a report on the Global Digital Pathology Market 2014-2018, which is expected to grow at a CAGR of 10.55 percent during 2013-2018.
Digital pathology, also referred to as virtual microscopy or virtual pathology, involves managing, interpreting, and analyzing the information from a digital slide. It is used in many applications such as forensic pathology, oral pathology, human pathology, and veterinary pathology. It has wide applications and is being used by pharmaceutical companies and education and research organizations.
“Personalized medicine offers a lot of opportunities for pathologists to improve patient care and make a correct diagnosis in less time,” says Faisal Ghaus, Vice President of TechNavio.
“Therefore, pathologists can offer a comprehensive assessment of a disease with the help of digital images that offer accurate images of the tumor cell and help in correlating the patterns.”
Key Market Drivers
- Rising Number of Cases in Oncology
- Need to Enhance Quality of Patient Care
- Advances in Digital Technology in Remote Patient Diagnosis
- Increased Demand from Emerging Markets
Key Market Trends
- Rise in Personalized Medicine
- Increased Demand for Advanced Analytical Tools
- Increased Usage in Diagnostic Industry
- Increased Usage of Hosted Technology
Key Market Vendors
- 3DHistech Inc.
- Hamamatsu Photonics Inc.
- Leica Biosystems Ltd.
- Ventana Medical Systems
To define the market circumstances in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
